From the Department of Plastic Surgery, Loma Linda University Medical Center; and Elson S. Floyd College of Medicine Washington State University.
Plast Reconstr Surg. 2021 May 1;147(5S):24S-30S. doi: 10.1097/PRS.0000000000008042.
Textured breast implants have garnered increased attention recently because of their risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), an uncommon and treatable type of T-cell lymphoma. Treatment involves bilateral en bloc capsulectomy, which is curative in the majority of cases. At present, there is no defined management approach for aesthetic patients asymptomatic for BIA-ALCL requesting the removal of their textured implants, particularly as it relates to the management of the capsule. It is unclear if en bloc capsulectomy is necessary in these patients as it is in patients with BIA-ALCL. In the absence of clear guidance on the management of the capsule in asymptomatic patients, the basic principles of breast revision surgery can be applied to these patients.
最近,由于其与乳腺癌相关的间变性大细胞淋巴瘤(BIA-ALCL)的风险,纹理乳房植入物受到了更多关注,BIA-ALCL 是一种罕见且可治疗的 T 细胞淋巴瘤。治疗方法包括双侧整块包膜切除术,在大多数情况下是治愈性的。目前,对于无症状的 BIA-ALCL 要求去除其纹理植入物的美容患者,尚未确定明确的管理方法,特别是与胶囊的管理有关。尚不清楚在这些患者中是否需要整块包膜切除术,就像在 BIA-ALCL 患者中一样。在没有关于无症状患者的胶囊管理的明确指导的情况下,可以将乳房修复手术的基本原则应用于这些患者。